explore -WSS

explore

author：hotspot 2025-09-30 15:17:03 - browse：42

Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024.

Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023. Humana also is “currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue,” according to the company’s update to investors.

Humana’s bad news for Wall Street didn’t end there: The company said it appears it only added just 100,000 new Medicare Advantage members from the most recent enrollment period that ended last month — down from estimates that it would enroll anywhere from 325,000 to 435,000 people.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Cell therapy fails to slow type 1 diabetes, but safety is established

explore

WSS

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

FTC falls short on scrutinizing hospital mergers, study says

Texas board proposes rules on abortion law emergency exemption

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Pfizer, Moderna say biotech, pharma drug development is a sprint

With Wegovy coverage, Medicare patients may face high costs

explore

explore

hotspot

Medical leaders decry Supreme Court decision on affirmative action

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Hepatitis C has a cure — but many Americans still lack access to it

Erich Jarvis studies song birds to learn about human stuttering

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Cue Health's Covid

Medical leaders decry Supreme Court decision on affirmative action

U.K. officials, researchers try to ease path for bespoke genetic treatments

Walensky prepares to leave CDC — and Congress — behind

Key Senate committee drafts bipartisan bill to stem drug shortages

leisure time

Chinese researcher claims birth of first gene

This gene therapy has record $4.25 million price. It's saved children.

After traumatic brain injury, life support decisions can use more time

Diversity in clinical trials starts with building trust, experts say

This gene therapy has record $4.25 million price. It's saved children.

H5N1 bird flu found in pasteurized milk: what we know

focus

explore

explore

Wikipedia